Castleman disease and depression

Castleman disease is a rare lymphoproliferative disorder that frequently impacts mental health due to its systemic inflammatory nature, chronic fatigue, and the stress of navigating an unpredictable illness. While clinical data on specific psychiatric prevalence in Castleman disease is limited, patients in the DiseaseMaps community and clinical settings often report significant challenges with anxiety and depression linked to symptom burden and the diagnostic journey.

Is there a link between Castleman disease and mental health?

The relationship between Castleman disease and depression is often bidirectional. Systemic inflammation—characterized by elevated cytokines like IL-6—is a hallmark of Castleman disease and may directly influence mood regulation and neuroinflammation. Furthermore, the chronic fatigue, persistent pain, and the uncertainty associated with managing Castleman disease create a significant psychological burden that can lead to secondary depressive symptoms.

What emotional challenges do patients face?

Living with Castleman disease involves unique stressors that can overwhelm coping mechanisms. Common psychological experiences include:

• Diagnostic fatigue: The rarity of Castleman disease often leads to long delays in diagnosis.


• Treatment anxiety: Managing ongoing therapies, such as immunotherapy or chemotherapy, induces significant stress.


• Isolation: Because Castleman disease is rare, patients may feel misunderstood by peers and even healthcare providers.


• Uncertainty: The fluctuating nature of the disease makes long-term planning difficult.

How can you recognize signs of depression?

It is vital to distinguish between normal illness-related exhaustion and clinical depression. Watch for:

1. Persistent feelings of hopelessness or worthlessness.


2. Loss of interest in activities once enjoyed.


3. Significant changes in sleep patterns or appetite that persist for more than two weeks.


4. Social withdrawal or difficulty concentrating on daily tasks.

How is mental health managed in this population?

Effective management requires an integrated approach. Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) are highly effective for managing the chronic stress of Castleman disease. Medication, such as antidepressants, may be indicated, though they must be carefully managed to avoid interactions with Castleman disease treatments. Support groups, such as the 59 members on DiseaseMaps.org, offer essential peer validation.

Next steps

• Consult your hematologist or oncologist for a referral to a psychologist experienced in chronic illness.


• Join the Castleman Disease community on DiseaseMaps.org to connect with others who understand your experience.


• If you are in crisis, please call or text 988 in the US or Canada, or contact your local emergency services immediately.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Castleman Disease


• Castleman Disease Collaborative Network (CDCN)


• Orphanet: Multicentric Castleman Disease


• PubMed: "The role of cytokines in neuroinflammation and mood disorders"